Salah Awad Alanazi

Salah Awad Alanazi is a Saudi Arabian healthcare research entity and clinical trial sponsor specializing in dental therapeutics and periodontology. The entity is currently advancing several clinical programs, including a Phase 1 study evaluating a locally applied ferulic acid nanoparticle gel as an adjunct to mechanical debridement for the treatment of periodontitis. Other research efforts include the evaluation of topical apremilast nanoformulations and the use of feracrylum for bleeding control in dental procedures. The entity operates in collaboration with academic institutions such as Mansoura University and Alfarabi College of Dentistry to develop novel drug delivery systems for oral health. Its work emphasizes the use of nanotechnology to enhance the efficacy of antioxidant and anti-inflammatory agents in managing chronic dental conditions.